IL159993A0 - Platinum complexes and their use in cancer treatment - Google Patents

Platinum complexes and their use in cancer treatment

Info

Publication number
IL159993A0
IL159993A0 IL15999302A IL15999302A IL159993A0 IL 159993 A0 IL159993 A0 IL 159993A0 IL 15999302 A IL15999302 A IL 15999302A IL 15999302 A IL15999302 A IL 15999302A IL 159993 A0 IL159993 A0 IL 159993A0
Authority
IL
Israel
Prior art keywords
platinum complexes
cancer treatment
present
concerns novel
novel platinum
Prior art date
Application number
IL15999302A
Other languages
English (en)
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Publication of IL159993A0 publication Critical patent/IL159993A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
IL15999302A 2001-08-23 2002-08-21 Platinum complexes and their use in cancer treatment IL159993A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31411501P 2001-08-23 2001-08-23
PCT/IL2002/000687 WO2003017998A1 (en) 2001-08-23 2002-08-21 Platinum complexes and their use in cancer treatment

Publications (1)

Publication Number Publication Date
IL159993A0 true IL159993A0 (en) 2004-06-20

Family

ID=23218625

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15999302A IL159993A0 (en) 2001-08-23 2002-08-21 Platinum complexes and their use in cancer treatment

Country Status (9)

Country Link
US (1) US7122668B2 (es)
EP (1) EP1420775B1 (es)
JP (1) JP2005501859A (es)
AT (1) ATE457992T1 (es)
CA (1) CA2456348A1 (es)
DE (1) DE60235375D1 (es)
ES (1) ES2339228T3 (es)
IL (1) IL159993A0 (es)
WO (1) WO2003017998A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9502799D0 (en) * 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
JP5107573B2 (ja) 2003-04-25 2012-12-26 ザ ペン ステイト リサーチ ファウンデーション 増殖抑制性脂質由来生物活性化合物の全身送達方法およびシステム
JP2007512318A (ja) * 2003-11-25 2007-05-17 プラトコ・テクノロジーズ・（プロプライエタリー）・リミテッド 白金（ｉｉ）錯体並びに該錯体の製法及び使用
EP2011798B1 (en) 2004-09-01 2011-06-29 Platco Technologies (Proprietary) Limited Preparation of platinum (II) complexes
ES2257178B1 (es) * 2004-09-30 2007-08-16 Universidad Autonoma De Madrid Compuestos de platino de formula trans-(ptc12(isopropilamina)(4-(hidroximetil)-piridina)) y trans-(ptc12(isopropilamina)(3-hidroximetil)-piridina y su aplicacion como farmaco antitumoral.
JP2009525273A (ja) * 2006-01-30 2009-07-09 プラットコー テクノロジーズ （プロプライエタリー） リミテッド 白金（ｉｉ）錯体の調製
US8173686B2 (en) 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8178564B2 (en) * 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168661B2 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US20100260832A1 (en) * 2007-06-27 2010-10-14 Poniard Pharmaceuticals, Inc. Combination therapy for ovarian cancer
US9265747B2 (en) 2008-08-26 2016-02-23 Massachusetts Institute Of Technology Platinum (IV) complexes for use in dual mode pharmaceutical therapy
EA201490067A1 (ru) 2011-06-21 2014-05-30 Массачусетс Инститьют Оф Текнолоджи Композиции и способы для лечения рака
AU2012300219A1 (en) * 2011-08-26 2014-03-06 The Regents Of The University Of California Platinum anticancer agents
WO2014160216A2 (en) 2013-03-13 2014-10-02 Massachusetts Institute Of Technology Dual targeting anticancer agents
WO2014165782A2 (en) * 2013-04-05 2014-10-09 Massachusetts Institute Of Technology Compositions, methods, and kits comprising platinum compounds associated with a ligand comprising a targeting moiety
CN103360431B (zh) * 2013-07-16 2015-07-01 山西大学 一种以8-氨基喹哪啶为母体的金属配合物及其合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7304882A (es) * 1972-04-10 1973-10-12
DE3777583D1 (de) * 1986-12-18 1992-04-23 Shionogi & Co Ammine-n-heterocyclische platinkomplexe und antitumormittel.
JPS63264492A (ja) * 1986-12-18 1988-11-01 Shionogi & Co Ltd アンミン−脂環系アミン白金錯体および抗腫瘍剤
US4921963A (en) * 1987-04-13 1990-05-01 British Columbia Cancer Foundation Platinum complexes with one radiosensitizing ligand
US5026694A (en) * 1987-04-13 1991-06-25 The British Columbia Cancer Foundation Platinum complexes with one radiosensitizing ligand
GB9502799D0 (en) * 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
CA2497025A1 (en) * 2002-09-11 2004-03-25 Board Of Regents, The University Of Texas System Platinum complexes as antitumor agents in combination with biochemical modulation

Also Published As

Publication number Publication date
CA2456348A1 (en) 2003-03-06
US7122668B2 (en) 2006-10-17
DE60235375D1 (de) 2010-04-01
WO2003017998A1 (en) 2003-03-06
JP2005501859A (ja) 2005-01-20
WO2003017998B1 (en) 2003-08-28
EP1420775A1 (en) 2004-05-26
EP1420775B1 (en) 2010-02-17
US20050090478A1 (en) 2005-04-28
ES2339228T3 (es) 2010-05-18
ATE457992T1 (de) 2010-03-15

Similar Documents

Publication Publication Date Title
IL159993A0 (en) Platinum complexes and their use in cancer treatment
MY126527A (en) Novel dihydropyrimidines
UA88645C2 (ru) Гетероарильные соединения как бета-миметики для лечения заболеваний дыхательных путей
BG105784A (en) Triazole compounds with dopamine-d3-receptor affinity
GEP20053488B (en) Novel Spiro Compounds
MY136520A (en) Novel compounds
HK1096392A1 (en) Substituted heterocycles
GB0111186D0 (en) Novel compounds
MXPA04003796A (es) Tioacetamidas sustituidas.
ZA200500908B (en) Ruthenium anticancer complexes
IL171974A0 (en) Tetrahydrocarbazole derivatives and their pharmaceutical use
HK1060729A1 (en) Inhibitors of cruzipain and other cysteine proteases
YU68702A (sh) Novi lhrh-antagonisti, njihova proizvodnja i upotreba kao leka
ATE333901T1 (de) Pharmazeutische zusammensetzung eines biguanin (metformin) und arginin
MY134026A (en) ?-carboline derivatives and its pharmaceutical use against depression and anxiety
HUP0402165A2 (hu) Nem neurotoxikus plazminogén aktiváló faktorok a szélhűdés kezelésére
EP1601756A4 (en) METHODS AND COMPOSITIONS FOR TREATING CANCER AND INFECTIOUS DISEASES USING ALPHA (2) MACROGLOBULIN ANTIGEN MOLECULE COMPLEXES
MXPA04001419A (es) Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson.
MXPA04001655A (es) Derivados de acido ascorbico, metodos de sintesis y uso farmaceutico de los mismos.
AU6011001A (en) Novel lhrh-antagonists, production and use thereof as medicament
MXPA02007903A (es) Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.
TW200504051A (en) Novel acridine derivatives and their use as medicaments
MXPA04000272A (es) Derivados de 4-aminociclohexanol sustituidos.
MXPA04004980A (es) Antagonistas del receptor ccr-3.
DE50006244D1 (en) Neue substituierte 3-phenoxy- und 3-phenylalkyloxy-2-phenyl-propylamine

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed